Literature DB >> 20406838

Imaging breast cancer chemotherapy response with light. Commentary on Soliman et al., p. 2605.

Bruce J Tromberg1, Albert E Cerussi.   

Abstract

Diffuse optical spectroscopy (DOS), which is used to image tumor metabolic response to neoadjuvant chemotherapy (NAC), shows large changes in tumor functional parameters with significant reductions in oxy- and deoxyhemoglobin for responders versus nonresponders. Although investigational, DOS may provide a cost-effective, risk-free method for optimizing NAC drug and dosing strategies for individual patients. Copyright 2010 AACR.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20406838      PMCID： PMC3204881          DOI： 10.1158/1078-0432.CCR-10-0397

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  12 in total

1.  Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI.

Authors:  Regine Choe; Alper Corlu; Kijoon Lee; Turgut Durduran; Soren D Konecky; Monika Grosicka-Koptyra; Simon R Arridge; Brian J Czerniecki; Douglas L Fraker; Angela DeMichele; Britton Chance; Mark A Rosen; Arjun G Yodh
Journal:  Med Phys       Date:  2005-04       Impact factor: 4.071

Review 2.  MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy.

Authors:  Nola Hylton
Journal:  Magn Reson Imaging Clin N Am       Date:  2006-08       Impact factor: 2.266

3.  Assessing the future of diffuse optical imaging technologies for breast cancer management.

Authors:  Bruce J Tromberg; Brian W Pogue; Keith D Paulsen; Arjun G Yodh; David A Boas; Albert E Cerussi
Journal:  Med Phys       Date:  2008-06       Impact factor: 4.071

4.  Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer.

Authors:  Hany Soliman; Anoma Gunasekara; Mary Rycroft; Judit Zubovits; Rebecca Dent; Jacqueline Spayne; Martin J Yaffe; Gregory J Czarnota
Journal:  Clin Cancer Res       Date:  2010-04-20       Impact factor: 12.531

5.  Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.

Authors:  Sina Meisamy; Patrick J Bolan; Eva H Baker; Robin L Bliss; Evin Gulbahce; Lenore I Everson; Michael T Nelson; Tim H Emory; Todd M Tuttle; Douglas Yee; Michael Garwood
Journal:  Radiology       Date:  2004-11       Impact factor: 11.105

6.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Authors:  B Fisher; J Bryant; N Wolmark; E Mamounas; A Brown; E R Fisher; D L Wickerham; M Begovic; A DeCillis; A Robidoux; R G Margolese; A B Cruz; J L Hoehn; A W Lees; N V Dimitrov; H D Bear
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

7.  Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy.

Authors:  S-J Kim; S-k Kim; E S Lee; J Ro; S h Kang
Journal:  Ann Oncol       Date:  2004-09       Impact factor: 32.976

8.  Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.

Authors:  David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Erin K Schubert; Jeffrey Tseng; Thomas J Lawton; Hannah M Linden; Robert B Livingston
Journal:  J Nucl Med       Date:  2003-11       Impact factor: 10.057

9.  Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study.

Authors:  Dorota B Jakubowski; Albert E Cerussi; Frédéric Bevilacqua; Natasha Shah; David Hsiang; John Butler; Bruce J Tromberg
Journal:  J Biomed Opt       Date:  2004 Jan-Feb       Impact factor: 3.170

10.  Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy.

Authors:  Albert Cerussi; David Hsiang; Natasha Shah; Rita Mehta; Amanda Durkin; John Butler; Bruce J Tromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205
View more
  6 in total

1.  Diffuse Optical Technology: A Portable and Simple Method for Noninvasive Tissue Pathophysiology.

Authors:  So Hyun Chung
Journal:  PET Clin       Date:  2012-01

2.  Performance assessment of diffuse optical spectroscopic imaging instruments in a 2-year multicenter breast cancer trial

Authors:  Thomas D. O'Sullivan; Albert Cerussi; Amanda Durkin; Brian Hill; Nola Hylton; Arjun G. Yodh; Stefan A. Carp; David Boas; Shudong Jiang; Keith D. Paulsen; Brian Pogue; Darren Roblyer; Wei Yang; Bruce J. Tromberg
Journal:  J Biomed Opt       Date:  2017-08-17       Impact factor: 3.170

3.  Rapid magnetic resonance-guided near-infrared mapping to image pulsatile hemoglobin in the breast.

Authors:  Zhiqiu Li; Venkataramanan Krishnaswamy; Shudong Jiang; Scott C Davis; Subhadra Srinivasan; Keith D Paulsen; Brian W Pogue
Journal:  Opt Lett       Date:  2010-12-01       Impact factor: 3.776

4.  Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy.

Authors:  Omar Falou; Hany Soliman; Ali Sadeghi-Naini; Sara Iradji; Sharon Lemon-Wong; Judit Zubovits; Jacqueline Spayne; Rebecca Dent; Maureen Trudeau; Jean Francois Boileau; Frances C Wright; Martin J Yaffe; Gregory J Czarnota
Journal:  Transl Oncol       Date:  2012-08-01       Impact factor: 4.243

5.  Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment.

Authors:  Darren Roblyer; Shigeto Ueda; Albert Cerussi; Wendy Tanamai; Amanda Durkin; Rita Mehta; David Hsiang; John A Butler; Christine McLaren; Wen-Pin Chen; Bruce Tromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-18       Impact factor: 11.205

6.  Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures.

Authors:  So Hyun Chung; Michael D Feldman; Daniel Martinez; Helen Kim; Mary E Putt; David R Busch; Julia Tchou; Brian J Czerniecki; Mitchell D Schnall; Mark A Rosen; Angela DeMichele; Arjun G Yodh; Regine Choe
Journal:  Breast Cancer Res       Date:  2015-05-27       Impact factor: 6.466
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.